JP2013529679A5 - - Google Patents

Download PDF

Info

Publication number
JP2013529679A5
JP2013529679A5 JP2013517669A JP2013517669A JP2013529679A5 JP 2013529679 A5 JP2013529679 A5 JP 2013529679A5 JP 2013517669 A JP2013517669 A JP 2013517669A JP 2013517669 A JP2013517669 A JP 2013517669A JP 2013529679 A5 JP2013529679 A5 JP 2013529679A5
Authority
JP
Japan
Prior art keywords
xylitol
injectable pharmaceutical
agent
pharmaceutical formulation
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013517669A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013529679A (ja
Filing date
Publication date
Priority claimed from IL206739A external-priority patent/IL206739A/en
Application filed filed Critical
Publication of JP2013529679A publication Critical patent/JP2013529679A/ja
Publication of JP2013529679A5 publication Critical patent/JP2013529679A5/ja
Pending legal-status Critical Current

Links

JP2013517669A 2010-06-30 2011-06-15 関節の処置のための注射用医薬組成物 Pending JP2013529679A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL206739 2010-06-30
IL206739A IL206739A (en) 2010-06-30 2010-06-30 An injectable drug containing silitol as an active substance
PCT/IL2011/000495 WO2012001679A1 (en) 2010-06-30 2011-06-15 Injectable pharmaceutical compositions for the treatment of joints

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016063344A Division JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Publications (2)

Publication Number Publication Date
JP2013529679A JP2013529679A (ja) 2013-07-22
JP2013529679A5 true JP2013529679A5 (https=) 2014-07-17

Family

ID=43569968

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013517669A Pending JP2013529679A (ja) 2010-06-30 2011-06-15 関節の処置のための注射用医薬組成物
JP2016063344A Expired - Fee Related JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016063344A Expired - Fee Related JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Country Status (9)

Country Link
US (2) US9913808B2 (https=)
EP (1) EP2588080B1 (https=)
JP (2) JP2013529679A (https=)
KR (1) KR101842295B1 (https=)
CA (1) CA2803257C (https=)
ES (1) ES2679279T3 (https=)
HU (1) HUE039724T2 (https=)
IL (1) IL206739A (https=)
WO (1) WO2012001679A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
EP4353311A3 (en) 2015-07-20 2024-07-17 The Brigham and Women's Hospital, Inc. Shear-thinning compositions as an intravascular embolic agent
IL272630B2 (en) 2017-08-22 2023-09-01 Moebius Medical Ltd Liposomal formulations for joint lubrication
KR20200000823A (ko) * 2018-06-25 2020-01-03 주식회사 씨아이에스티이엠 인간 유도 만능 줄기세포로부터 연골세포의 펠렛을 제조하는 방법 및 이의 용도
US20240099989A1 (en) * 2021-02-05 2024-03-28 Kinki University Agent for preventing or improving peripheral neuropathy
CA3266614A1 (en) 2023-01-19 2024-07-25 Moebius Medical Ltd. LONG-ACTING LIPOSOMAL COMPOSITION FOR THE TREATMENT OF PAIN IN JOINT DISORDERS

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5095037B1 (en) 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
JP2788340B2 (ja) 1989-12-21 1998-08-20 株式会社ニッショー 炎症治療剤
AUPM922394A0 (en) * 1994-11-03 1994-11-24 Astra Pharmaceuticals Pty Ltd Plastic syringe with overcap
DE69633818T2 (de) 1995-08-07 2005-12-08 Suntory Ltd. Verwendung eines mittels zur zur vorbeugung oder behandlung von durch anomalitäten des knorpelgewebes verursachten erkrankungen
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
EP1092447B1 (en) * 1999-10-14 2004-01-07 Becton Dickinson and Company Nasal delivery device including spray nozzle
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
FR2833173B1 (fr) 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
UA82561C2 (uk) * 2003-10-23 2008-04-25 Оцука Фармасьютикалз Ко., Лтд. Стерильна ін'єкційна композиція арипіпразолу з контрольованим вивільненням, спосіб її виготовлення та спосіб лікування шизофренії
EP1898930A4 (en) * 2005-06-17 2009-12-09 Dynamis Therapeutics Inc Treatment of inflammatory conditions
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
CN101209344B (zh) * 2006-12-28 2012-07-04 赵超英 高渗液组合物在制备促进伤口愈合的药物中的应用
CN101450037A (zh) * 2007-11-28 2009-06-10 天津太平洋制药有限公司 一种木糖醇静脉注射液及其制备方法
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
CN101669962A (zh) * 2009-09-18 2010-03-17 杭州市第六人民医院 复合甘草酸氨基酸注射液及其制备方法和应用
CN101664384B (zh) * 2009-09-18 2011-09-14 杭州市第六人民医院 N-乙酰半胱氨酸盐木糖醇注射液及其制备方法和应用
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
WO2012143876A1 (en) 2011-04-19 2012-10-26 Anteis S.A. A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint

Similar Documents

Publication Publication Date Title
JP2013529679A5 (https=)
JP2014505733A5 (https=)
JP2014240439A5 (https=)
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP2012012418A5 (https=)
HRP20250200T1 (hr) Farmaceutski pripravci koji sadrže meloksikam
BR112014011504A2 (pt) forma de dosagem farmacêutica oral inviolável compreendendo ingrediente farmacologicamente ativo, antagonista opioide e/ou agente aversivo, óxido de polialquileno e polímero aniônico
HRP20221294T1 (hr) Neuroaktivni steroidi, njihovi pripravci i uporabe
BR112013022788A2 (pt) "composição farmacêutica compreendendo uma dispersão sólida de 1-(4-benzidrilpiperazin-1-il)-3,3-difenilpropan-1-ona"
HRP20200567T1 (hr) Stabilni injektabilni farmaceutski pripravci koji sadrže 2-hidroksipropil-beta-ciklodekstrin i alfaksalon
BR112017006957A2 (pt) formulações farmacêuticas para a liberação por via oral de fármacos do tipo de peptídeo ou proteína
JP2011521969A5 (https=)
MX382192B (es) Composiciones de canabinoide y usos.
BR112015017246A8 (pt) composição farmacêutica aquosa, seu uso e seringa
AR068816A1 (es) Composiciones de brimonidina mejorada para el tratamiento del eritema
HRP20141009T1 (hr) Novi sastavi za lijeäśenje cmt i povezanih poremeä†aja
BRPI0508933A (pt) composições para entrega tópica
AU2018258159A1 (en) Ultrapure tetrahydrocannabinol-11-oic acids
MX2014008283A (es) Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
WO2013022243A3 (ko) 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물
WO2015019304A3 (fr) Compositions à libération continue à base d'acide hyaluronique, et leurs applications thérapeutiques
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
RS52620B (sr) Upotreba hitosana za lečenje inflamatornih bolesti noktiju
HK1222337A1 (zh) 用於施加药物活性成分或化妆品活性成分的局部组合物和载体
HK1215672A1 (zh) 用於治療炎症和癌症的吲哚類化合物